Johnson & Johnson (JNJ)
155.46
+0.43 (0.28%)
NYSE · Last Trade: Jun 9th, 12:33 PM EDT
Via Benzinga · June 9, 2025
With earnings season coming to an end, investors are looking for new catalysts; here are three blue-chip companies with strong analyst support
Via MarketBeat · June 6, 2025

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.
Via Benzinga · June 5, 2025

Rosnilimab met key RA trial goals, with sustained clinical responses and safety benefits, prompting an analyst upgrade and price target hike to $38.
Via Benzinga · June 4, 2025

Johnson & Johnson shared positive ASCO 2025 results, including improved survival and remission in prostate and multiple myeloma patients.
Via Benzinga · June 3, 2025

These stocks are ready for a summer surge.
Via The Motley Fool · June 3, 2025

For long-term investors looking for both stability and innovation in the healthcare space, JNJ is a rare combination of both.
Via Talk Markets · May 31, 2025

Via The Motley Fool · May 29, 2025

Michael Mahoney's grandfather was a cardiac surgeon — so his first career plan was to become a doctor. Mahoney didn't give up — he adjusted.
Via Investor's Business Daily · May 29, 2025
Teva starts IND-enabling studies for BD9, a dual-target therapy for asthma and atopic dermatitis, under license from Biolojic Design.
Via Benzinga · May 27, 2025
Activist investor Dan Loeb's Third Point LLC acquired a significant stake in consumer health company Kenvue Inc. in Q1 2025.
Via Benzinga · May 27, 2025
Via The Motley Fool · May 27, 2025
Johnson & Johnson (NYSE:JNJ) offers a strong dividend yield, consistent growth, and solid profitability, making it a compelling choice for income investors.
Via Chartmill · May 26, 2025
Via The Motley Fool · May 25, 2025
Via The Motley Fool · May 24, 2025
Via The Motley Fool · May 23, 2025
For buy-and-hold investors looking for some quality names to navigate a turbulent market, here are three stocks to consider
Via MarketBeat · May 22, 2025
US companies are reshoring manufacturing operations & investing billions in the country, led by Apple & Nvidia for tech, J&J & Eli Lilly for healthcare, Anheuser-Busch for beer, & Cra-Z-Art for toys. Detroit & beyond are benefiting from this trend.
Via Benzinga · May 20, 2025
Warren Buffett has had a lot of successful investments, but one in particular has crushed the stock market time and again.
Via The Motley Fool · May 18, 2025